Skip to search formSkip to main contentSkip to account menu

AH 3474

Known as: AH-3474, benzamide, 5-(2-((1,1-dimethylethyl)amino)-1-hydroxyethyl)-2-hydroxy- 
National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

Ethanolamines

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1969
1969
The pharmacology of 5‐(2‐t‐butylamino‐1‐hydroxyethyl) salicylamide (AH 3474), a β‐adrenoreceptor blocking agent
AH 3474 is a specific β‐adrenoreceptor antagonist, devoid of stimulant activity. When given by mouth to conscious guinea‐pigs and… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)